JG
ABEO icon

Jain Global’s Abeona Therapeutics ABEO Stock Holding History

Jain Global’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Buy
+28,885
New +$159K ﹤0.01% 1544
2026
Q1 		– Sell
-366,067
Closed -$1.93M – 1163
2025
Q4 		$1.93M Buy
+366,067
New +$1.84M 0.01% 598
2025
Q3 		– Sell
-111,277
Closed -$632K – 970
2025
Q2 		$632K Buy
111,277
+65,337
+142% +$372K ﹤0.01% 742
2025
Q1 		$219K Buy
+45,940
New +$250K ﹤0.01% 818

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jain Global's ABEO Position: Q2 2026 in Review

Jain Global opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 28,885 shares worth $179K. The stake represents ﹤0.01% of the portfolio and ranks #1544 among its holdings. This is a return to the name: Jain Global previously reported a position in ABEO as recently as Q4 2025.

Jain Global first reported a position in ABEO in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.93M in Q4 2025. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Jain Global held 28,885 shares of Abeona Therapeutics worth $179K as of Q2 2026.
  • Abeona Therapeutics was a new Jain Global position in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1544 holding.
  • Jain Global first reported a position in Abeona Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Jain Global's Abeona Therapeutics position peaked at $1.93M in Q4 2025.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.